The effect of Fluocinolone Acetonide Implant (Iluvien) in patients with diabetic macular edema (DME) with prior no, or sub-optimal response to Dexamethasone implants (INDEX Study)

被引：0
|
作者：
Habib, Maged [2 ]
Cheema, Muhammad Raza [1 ]
Tzoumas, Nikolaos [1 ]
Masri, Ibrahim [1 ]
Smith, Jonathan [1 ]
Grinton, Michael Edward [1 ]
Varma, Deepali [1 ]
Steel, David H. W. [1 ,2 ]
Kotagiri, Ajay [1 ]
机构：
[1] Sunderland Eye Infirm, Ophthalmol, Sunderland, Tyne & Wear, England
[2] Newcastle Univ, Biosci Inst, Newcastle Upon Tyne, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Correction to: Iluvien™ (Fluocinolone Acetonide 0.19 mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    William Fusi-Rubiano
    Rebecca R. Blow
    Mark Lane
    Rupal Morjaria
    Alastair K. Denniston
    Ophthalmology and Therapy, 2020, 9 : 205 - 205
  • [12] Iluvien (Fluocinolone Acetonide 0.19mg Intravitreal Implant) in the Treatment of Diabetic Macular Edema: A Review
    Fusi-Rubiano, William
    Blow, Rebecca R.
    Lane, Mark
    Morjaria, Rupal
    Denniston, Alastair K.
    OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 293 - 305
  • [13] Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant
    Baillif, Stephanie
    Staccini, Pascal
    Weber, Michel
    Delyfer, Marie-Noelle
    Le Mer, Yannick
    Gualino, Vincent
    Collot, Laurence
    Merite, Pierre-Yves
    Creuzot-Garcher, Catherine
    Kodjikian, Laurent
    Massin, Pascale
    PHARMACEUTICS, 2022, 14 (11)
  • [14] Efficacy and Safety of Fluocinolone Acetonide Implant (Iluvien®) in Postoperative Cystoid Macular Edema: ILUCYD study
    Motloch, Karolina
    Couturier, Aude
    Delyfer, Marie-Noelle
    Vasseur, Vivien
    Wolff, Benjamin
    Issa, Mohamad
    Dot, Corinne
    Weber, Michel
    Comet, Alban
    Hitzl, Wolfgang
    Garcher, Catherine P. Creuzot
    Kodjikian, Laurent
    Tadayoni, Ramin
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [15] Fluocinolone acetonide ( FAc) 0.2 mg intravitreal implant in the treatment of diabetic macular edema (DME)
    Liu, John
    Coney, Joseph
    Schartman, Jerome
    Miller, David G.
    Zegarra, Hernando
    Rao, Llewelyn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [16] Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)
    McCluskey, Jessica D.
    Kaufman, Paul L.
    Wynne, Kathy
    Lewis, Gregory
    INTERNATIONAL MEDICAL CASE REPORTS JOURNAL, 2019, 12 : 93 - 102
  • [17] Efficacy and safety of corticosteroid implant (Fluocinolone Acetonide (FAc) 0.2 lg/day, Iluvien ®) for management of Diabetic Macular Edema (DME): a real-life study
    Vieira, M.
    Pereira, J.
    Santos, M.
    Arruda, H.
    Sousa, J.
    ACTA OPHTHALMOLOGICA, 2018, 96 : 135 - 136
  • [18] Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)-results from the ILUVIT study
    Deuchler, Svenja K.
    Schubert, Ralf
    Singh, Pankaj
    Chedid, Adonis
    Kenikstul, Ninel
    Scott, Julia
    Kohnen, Thomas
    Ackermann, Hanns
    Koch, Frank
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (08) : 2537 - 2547
  • [19] Vitreous cytokine levels following the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema (DME)—results from the ILUVIT study
    Svenja K. Deuchler
    Ralf Schubert
    Pankaj Singh
    Adonis Chedid
    Ninel Kenikstul
    Julia Scott
    Thomas Kohnen
    Hanns Ackermann
    Frank Koch
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 2537 - 2547
  • [20] The use of intravitreal implant ILUVIEN ® (fluocinolone acetonide) after prior OZURDEX ® Implant (DEX) (Dexamathason) in patients with diabetic macular edema (DME) - Efficacy and safety outcomes from the University Eye Clinic in Frankfurt, Germany
    Singh, Pankaj
    Chedid, Adonis
    Deuchler, Svenja
    Kohnen, Thomas
    Mueller, Michael
    Koch, Frank H. J.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
12345